Clinical trialNCT00528593WithdrawnPhase 2Interventional

Epoetin Alfa for HIV-Associated Neuropathy Trial

SponsorWashington University School of MedicineEnrollment0HIV InfectionsNeuropathy

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the effect of epoetin alfa on HIV-associated neuropathy by measuring changes in nerve fiber density and pain ratings.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Bruce Cohen, MD
Professor of Neurology, Northwestern University
Principal Investigator
clinicaltrials.gov ↗
David B. Clifford, MD
Professor of Neurology, Washington University
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
David Simpson, MD
Professor of Neurology, Mt. Sinai Medical Center
Principal Investigator
clinicaltrials.gov ↗
Justin McArthur, MBBS, MPH
Professor of Neurology, Johns Hopkins University
Study Chair
clinicaltrials.gov ↗
Pablo Tebas, MD
Associate Professor of Medicine, University of Pennsylvania
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Epoetin alfa →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Nov 2007
Primary completion: 31 Oct 2009
Completion: 31 Oct 2009
Last update posted: 9 Aug 2011
Registered enrollment: 0
Registry id: NCT00528593

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.